Your browser doesn't support javascript.
loading
Pharmacokinetics of the Port Delivery System with Ranibizumab in the Ladder Phase 2 Trial for Neovascular Age-Related Macular Degeneration.
Wykoff, Charles C; Campochiaro, Peter A; Pieramici, Dante J; Khanani, Arshad M; Gune, Shamika; Maia, Mauricio; Kågedal, Matts; Ding, Han Ting; Maass, Katie F.
Afiliação
  • Wykoff CC; Retina Consultants of Texas, 4460 Bissonnet Street, Suite 200, Bellaire, TX, 77401, USA. charleswykoff@gmail.com.
  • Campochiaro PA; Department of Ophthalmology, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Pieramici DJ; California Retina Consultants, Santa Barbara, CA, USA.
  • Khanani AM; Sierra Eye Associates, Reno, NV, USA.
  • Gune S; The University of Nevada, Reno School of Medicine, Reno, NV, USA.
  • Maia M; Genentech, Inc., South San Francisco, CA, USA.
  • Kågedal M; Genentech, Inc., South San Francisco, CA, USA.
  • Ding HT; Genentech, Inc., South San Francisco, CA, USA.
  • Maass KF; Genentech, Inc., South San Francisco, CA, USA.
Ophthalmol Ther ; 11(5): 1705-1717, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35759124
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article